![Judith Ann Hemberger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Judith Ann Hemberger
Vorstandsvorsitzender bei
SuviCa, Inc.
Profil
Judith Ann Hemberger was the founder of Pharmion Corp.
(founded in 2000) where she held the title of Chief Operating Officer & EVP.
She is currently the Chairman & Chief Executive Officer at SuviCa, Inc. and a Director at the Parkinson's Institute & Clinical Center.
In her former positions, Dr. Hemberger served as Chairman at Clarimedix, Inc., Director at Perrigo Co., NeXstar Pharmaceuticals, Inc., Cell Pathways, Inc., Renovis, Inc., VasoGenix Pharmaceuticals, Inc., Gilead Colorado, Inc., Novacea, Inc., Chroma Therapeutics Ltd., HealthShares, Inc., The Schein Group, Inc., Algeta ASA, Atani Ltd., and Phase4 Partners Ltd. She was also the SVP-Business Development at AVAX Technologies, Inc. from 1997 to 1999 and held the title of Partner at Phase4 Partners Ltd. in 2009.
Additionally, she served as SVP-Global Drug Regulatory Affairs at Marion Merrell Dow, Inc. and Hoechst Marion Roussel, Inc.Dr. Hemberger obtained an MBA from Rockhurst University, a doctorate from the University of Missouri, and an undergraduate degree from Benedictine College.
Aktive Positionen von Judith Ann Hemberger
| Unternehmen | Position | Beginn |
|---|---|---|
SuviCa, Inc.
 SuviCa, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Vorstandsvorsitzender | - |
Parkinson's Institute & Clinical Center
 Parkinson's Institute & Clinical Center Medical/Nursing ServicesHealth Services Operates as non-profit organization, which provides comprehensive patient care services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Judith Ann Hemberger
| Unternehmen | Position | Ende |
|---|---|---|
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Direktor/Vorstandsmitglied | 28.10.2009 |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 03.02.2009 |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Corporate Officer/Principal | 01.01.2009 |
| PRA HEALTH SCIENCES, INC. | Direktor/Vorstandsmitglied | 13.12.2007 |
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for cardiovascular diseases | Direktor/Vorstandsmitglied | 17.11.2006 |
Ausbildung von Judith Ann Hemberger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
26
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 26 |
|---|---|
Perrigo Co.
 Perrigo Co. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets self-care products and solutions | Health Technology |
NeXstar Pharmaceuticals, Inc.
 NeXstar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
AVAX Technologies, Inc.
 AVAX Technologies, Inc. BiotechnologyHealth Technology Operates as development stage company with interest in the development and future commercialization of individualized cancer vaccines | Health Technology |
PRA Health Sciences, Inc.
 PRA Health Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services for pharmaceutical & biotechnology companies | Commercial Services |
Cell Pathways, Inc.
 Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat cancer | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
VasoGenix Pharmaceuticals, Inc.
 VasoGenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cardiology drug products | Health Technology |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for cardiovascular diseases | Health Technology |
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Health Technology |
Clarimedix, Inc.
 Clarimedix, Inc. Medical SpecialtiesHealth Technology Develops pipeline products for diseases associated with vascular dysfunction | Health Technology |
Rockhurst University
 Rockhurst University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marion Merrell Dow, Inc.
 Marion Merrell Dow, Inc. Pharmaceuticals: MajorHealth Technology Brand name drug company | Health Technology |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Benedictine College
 Benedictine College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Engages in the discovery and development of therapies for the treatment of cancer and inflammation | Health Technology |
HealthShares, Inc.
 HealthShares, Inc. Investment Trusts/Mutual FundsMiscellaneous Exchange Traded Fund | Miscellaneous |
The Schein Group, Inc. | |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Hoechst Marion Roussel, Inc.
 Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
Atani Ltd.
 Atani Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets drugs | Health Technology |
Parkinson's Institute & Clinical Center
Parkinson's Institute & Clinical Center Medical/Nursing ServicesHealth Services Operates as non-profit organization, which provides comprehensive patient care services | Health Services |
SuviCa, Inc.
SuviCa, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
